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Dcatheter-based, and/or surgical intervention in the manage-
ment of these challenging patients.
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Dr Christopher Caldarone (Toronto, Ontario, Canada). Dr
Woods, my congratulations on an excellent presentation. This
study is very important because it clearly demonstrates the value
of widely adopted registries like the STS database, and not surpris-
ingly, you have shown that the mortality rate for these procedures
is much higher than in single-center reported series, which we all
know are biased toward reporting favorable results, and therein I
suspect lies the most important message of your study. The price
for this broad perspective, however, is an inevitable loss of detail,
and this is where I would like to ask a few questions.
Forty percent of the infants in your series underwent surgical
procedures prior to the index procedure described in your analy-
sis. In addition, there is some unknown number of cardiology-
based procedures that also may have been performed. For those
in the audience not familiar with this particular problem, patients
with left ventricular outflow tract obstruction commonly have as-
sociated lesions at the mitral, ventricular, valvar, and aortic arch
levels. Can you shed some more light on the impact of these pre-
operative procedures on the procedure-based cohort you have
described?
Dr Woods. Thank you for your question, Dr Caldarone. To ad-
dress the issue of procedures either prior to or subsequent to the
aortic valve replacement procedure with the STS database would
require both a combination of linkage potentially across multiple
admissions as well as a greater level of granularity in the data per-
taining to additional procedures, particularly catheter-based
procedures.
And as you are probably aware, the upgrade schedule for the da-
tabase in January of next year will have some important changes. It
will include diagnostic codes that include status postprocedural
codes to provide additional procedural information. It will also
permit linkage not only across admissions, but also to potential
other sources of data and, in particular, the IMPACT registry of
the American College of Cardiology. So with these changes I
think, in the future, it should be possible to address some of these
issues that you bring up.
What we are left with at present is what has been published, and
certainly you and your colleagues from the Congenital Heart Sur-
geons Society I believe published in the European Journal of Car-
diothoracic Surgery in 2010 and more recently this year in
February in the Journal of Thoracic and Cardiovascular Surgery
regarding some of these issues. Based on those results, multiple
procedures are not uncommon and overall survival appears to be
compromised by the cumulative procedural risk.
Dr Caldarone. You reported that concomitant aortic arch sur-
gery is associated with higher mortality, suggesting that greater
left-sided hypoplasia is associated with more mortality. Surpris-
ingly, concomitant mitral surgery was not a risk factor for death.
Do you suspect that we as a profession have successfully neutral-
ized the mitral valve issue or are we simply getting better at iden-
tifying irreparable mitral anomalies and shunting these patients
into a single ventricle pathway, an event that would not be detected
in your analysis?
Dr Woods. What you imply or suggest may be true, but our
study wasn’t designed to look at temporal trends and outcomes
with concomitant mitral surgery nor in improvements in patient se-
lection. I acknowledge the manuscript that you and yourdiovascular Surgery c Volume 144, Number 5 1089
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Dcolleagues from Toronto published I believe in the Annals of Tho-
racic Surgery recently in which you evaluated mitral surgery ver-
sus no mitral surgery in the Ross-Konno group. Clearly, there was
higher mortality with concomitant mitral surgery. I don’t need to
cite your own data to you, you know it very well, but for the
sake of the audience, as I recall, there were 8 patients who had mi-
tral surgery and their median age was approximately 300 days. For
the group that didn’t havemitral surgery, therewere approximately
12 patients, and their median age approached almost 6 years. That
is considerably older than the group of patients with concomitant
mitral surgery in the current cohort. To the extent that is relevant, I
don’t know. In the study from Ann Arbor, mortality occurred ex-
clusively in patients who had either concomitant arch or mitral sur-
gery, but actually I think there were only 2 patients in that study
who had concomitant mitral surgery.
From an intuitive standpoint I think many of us, myself in-
cluded, would be expecting higher mortality with concomitant sur-
gery. The cohort we present today certainly has the largest number
of patients with concomitant mitral surgery, but that doesn’t really
answer the issue because we don’t know for those patients in the
current cohort who didn’t have mitral surgery, the degree to which
they were actually free of mitral valve disease, and I think without
that information it is hard to really know the true answer. So I think
it is an unresolved issue.
Dr Caldarone. Well, like all good studies, you have raised
more questions than you have answered. So I congratulate you
and urge you and your colleagues to continue studying this very
interesting cohort.
Dr Vaughan Starnes (Los Angeles, Calif). Dr Woods, thank
you for the information that you have just presented. I am going
to ask you to speculate. Given that the mortality and the complica-
tions with homograft insertions are equal to that of the Ross pro-
cedure, and knowing the limited survival rate of those1090 The Journal of Thoracic and Cardiovascular Surhomografts in infants, anywhere from 5 months to 1 year durabil-
ity, would you say that homografts are still indicated in that age
group?
Dr Woods. Thank you for your question, Dr Starnes. I don’t
think our data really answer that question. In an elective setting
for aortic stenosis, with rare exception, the Ross procedure would
seem to be the preferred approach. For those patients who present
acutely with wide-open insufficiency in a really compromised
state, it may be that their early outcomes are defined more by
the presenting physiologic condition as opposed to the type of pro-
cedure. It is a difficult question and I am not certain I have an an-
swer for you, Dr Starnes.
Dr Starnes. Thank you.
Dr Emile Bacha (New York, NY). Ron, a great talk. Thank you
for pointing out the hard, cold fact that these patients have a high
mortality and comparing them with other high-mortality proce-
dures that we do, such as the Norwood procedure. I would like
to have your impression on whether this is not maybe a judgment
problem rather than a technical problem. We can do AVRs in ne-
onates, but it should be a very rare procedure, and so the question
is really whether some of these patients shouldn’t have had anAVR
and rather gone down the single ventricle route.
Dr Woods. That is really the home run question, I think, Dr
Bacha, as you point out. Certainly, early survival is the first goal,
and based on the present cohort, a neonatal Ross-Konno appears
to have a higher mortality than a stage 1 Norwood. I think when
confronted at the bedside with a patient and one is considering
a single versus a biventricular strategy, if that patient has disease
at more than just the valvar and subvalvar levels, particularly if
the ventricle is on the smaller side and/or some degree of endocar-
dial fibroelastosis is present, I think one would be very prudent to
think long and hard before pushing that patient down an initial bi-
ventricular pathway.gery c November 2012
